Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
1 Department of Pediatrics, Stanford University School of Medicine, California, USA. pmazur@stanford.edu.
2 Department of Genetics, Stanford University School of Medicine, California, USA. pmazur@stanford.edu.
3 Second Department of Internal Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
4 Department of Genetics, Stanford University School of Medicine, California, USA.
5 Department of Radiation Oncology, Stanford University School of Medicine, California, USA.
6 Department of Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
7 David H. Koch Institute for Integrative Cancer Research, Department of Biology, and Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
8 Department of Medicine, Stanford University School of Medicine, California, USA.
9 Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, California, USA.
10 Department of Pediatrics, Stanford University School of Medicine, California, USA.
11 Department of Molecular Gastrointestinal Oncology, Ruhr-University Bochum, Bochum, Germany.
12 Ruhr-University Bochum, Medical Clinic, Knappschaftskrankenhaus, Bochum, Germany.
13 Institute of Radiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
14 Department of Surgery, Koc University School of Medicine, Istanbul, Turkey.
15 Institute of Pathology, University of Tübingen, Tübingen, Germany.
16 Institute of Virology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
17 Division of Chronic Inflammation and Cancer, German Cancer Research center (DKFZ), Heidelberg, Germany.
18 Department of Gastroenterology and Gastrointestinal Oncology, University Medical Center Göttingen, Göttingen, Germany.
19 Institute of Pathology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
20 Institute of Pathology, Heinrich-Heine University, Düsseldorf, Germany.
21 Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
22 German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
23 Department of Pediatrics, Stanford University School of Medicine, California, USA. julsage@stanford.edu.
24 Department of Genetics, Stanford University School of Medicine, California, USA. julsage@stanford.edu.
25 Second Department of Internal Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. j.siveke@dkfz.de.
26 German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany. j.siveke@dkfz.de.
27 Division of Translational Solid Tumor Oncology, German Cancer Consortium (DKTK), partner site Essen and German Cancer Research Center (DKFZ), Heidelberg, Germany. j.siveke@dkfz.de.